CD274 and head and neck squamous cell carcinoma: The reversal of immune rejection mediated by tadalafil and antitumor vaccines also resulted in the up-regulation of PD-L1 in recurrent HNSCC, indicating that immune checkpoint therapy may be equally effective in patients with recurrent HNSCC (8).